Back

Longitudinal impact of lipid levels on subclinical atherosclerosis in adolescents: insights from the LOOK study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipids (3) Lipids ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Christian Abhayaratna

Royal Prince Alfred Hospital, Sydney (Australia)

6 More presentations in this session

Presentation thumbnail
Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia
Doctor H. Tada (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
The effect of baseline prediabetes on the relation between lipoprotein (a) and incident type 2 diabetes and outcome: observations from the UK-Biobank.
Doctor J. Sangha (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Lipoprotein-(a) and mitral annular calcification: a systematic review and meta-analysis
Doctor K. Kyriakoulis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Unmet needs of LDL C lowering in ACS patients when using only high intensity statins puts at setback
Doctor S. Ramraika (Lucknow, IN)
Abstract Slides Video
Presentation thumbnail
The determinants of lack of atherosclerosis progression in adult patients with elevated lipoprotein(a). The results from the STAR-Lp(a) study.
Professor M. Banach (Lodz, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Trajectories of lipid profile during adolescence and risk of subclinical atherosclerosis in early adulthood: a two-decade population-based study
thumbnail
Congress Presentation
Elevated triglycerides are related to higher residual cardiovascular disease and mortality risk independent of lipid targets and lipid-lowering therapy intensity in cardiovascular disease patients
thumbnail
Congress Presentation
The Triglycerides - Glucose Index: An independent predictor of late subclinical cardiotoxicity in adult survivors of childhood, adolescent and young adult cancer

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources